First-line chemotherapy for ovarian cancer – the controversy continues
Open Access
- 7 October 2002
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 87 (8), 813-814
- https://doi.org/10.1038/sj.bjc.6600568
Abstract
British Journal of Cancer (2002) 87, 813–814. doi:10.1038/sj.bjc.6600568 www.bjcancer.comKeywords
This publication has 3 references indexed in Scilit:
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI Journal of the National Cancer Institute, 2000
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosisNature Medicine, 1996